Ibere Pharmaceuticals Cl A (IBER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 234 | 95 | 0 |
| Operating Income | -234 | -95 | N/A |
| Other Income | 122 | -311 | 0 |
| Pre-tax Income | -112 | -406 | 0 |
| Net Income Continuous | -112 | -406 | N/A |
| Net Income | $-112 | $-406 | $N/A |
| EPS Basic Total Ops | -0.01 | -0.88 | N/A |
| EPS Basic Continuous Ops | -0.03 | -0.13 | N/A |
| EPS Diluted Total Ops | -0.01 | -0.88 | N/A |
| EPS Diluted Continuous Ops | -0.03 | -0.13 | N/A |
| EBITDA(a) | $-234 | $-95 | $N/A |